Scientists Discover Protein Found in Tobacco Plant Could Fight Infectious Diseases
A team of scientists from Melbourne's La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases. The scientific discovery, published in the prestigious journal Nature Communications, could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr. Mark Hulett and Dr. Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
"Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years," Hulett said.
"Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It's imperative we develop new antibiotic treatments."
Using the power of the Australian Synchrotron, the team led by Hulett and Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
"They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
"It's an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multidrug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis."
In 2014, Hulett and Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent antifungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
The research was funded by The Australian Research Council and La Trobe University.
Source: La Trobe University
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
